{"id":134293,"name":"NATIONAL COMMUNITY PHARMACISTS ASSOCIATION","slug":"national-community-pharmacists-association","state":"VA","country":"United States of America","description":"","totalSpending":15352000,"filings":34,"yearlySpending":[{"year":2018,"income":1250000},{"year":2019,"income":1280000},{"year":2020,"income":1460000},{"year":2021,"income":3680000},{"year":2022,"income":3190000},{"year":2023,"income":1440000},{"year":2024,"income":1792000},{"year":2025,"income":1260000}],"issues":["ALC","HCR","MMM","DEF","BUD","ANI","PHA","TAX","LBR","INS","SMB","TEC","TRD"],"firms":["NATIONAL COMMUNITY PHARMACISTS ASSOCIATION"],"lobbyists":["KARRY LA VIOLETTE","RONNA HAUSER","PHILLIP HARBISON","KEVIN SCHWEERS","SUSAN PILCH","KALA SHANKLE","ANNE CASSITY","REEMA TANEJA","SHION CHANG","PETER MIHALICK","MATTHEW SEILER","KAITLIN KRELL","STEVEN POSTAL","DAVID WEISSMAN"],"govEntities":["Agriculture, Dept of (USDA)","Centers For Medicare and Medicaid Services (CMS)","Defense, Dept of (DOD)","Drug Enforcement Administration (DEA)","Food & Drug Administration (FDA)","Government Accountability Office (GAO)","Health & Human Services, Dept of (HHS)","Health Resources & Services Administration (HRSA)","HOUSE OF REPRESENTATIVES","Medicare Payment Advisory Commission (MedPAC)","Office of Management & Budget (OMB)","Office of Natl Drug Control Policy (NDCP)","Office of Personnel Management (OPM)","SENATE","Substance Abuse & Mental Health Services Administration (SAMHSA)","White House Office","Environmental Protection Agency (EPA)","Small Business Administration (SBA)","Internal Revenue Service (IRS)","Labor, Dept of (DOL)","Centers For Disease Control & Prevention (CDC)","Federal Trade Commission (FTC)","Federal Reserve System","Justice, Dept of (DOJ)","Occupational Safety & Health Administration (OSHA)","Treasury, Dept of","U.S. Customs & Border Protection","Commerce, Dept of (DOC)"],"sampleDescriptions":["Implementation of Public Law 114-198 pharmacy provisions&#205;&#190; \nImplementation of Public Law 114-255 pharmacy provisions; \nH.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017;\nS 892 / H.R","S. 469, Affordable and Safe Prescription Drug Importation Act; \nH.R. 1245, Affordable and Safe Prescription Drug Importation Act; \nH.R. 1776, Improving Access to Affordable Prescription Drugs Act; \nS.","H.R. 1316, Prescription Drug Price Transparency Act&#205;&#190; \nH.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; \nS. 413, Improving Transparency and Accuracy in Medicar","Tricare pharmacy working group","Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act&#205;&#190; \nH.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; \nS.934 FDA Reauthorization A"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}